Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Broadcom
AVGO
|
$784M |
| 2 |
Amgen
AMGN
|
$695M |
| 3 |
Eli Lilly
LLY
|
$512M |
| 4 |
Apple
AAPL
|
$485M |
| 5 |
Alphabet (Google) Class C
GOOG
|
$471M |
Top Sells
| 1 |
Adobe
ADBE
|
$935M |
| 2 |
NVIDIA
NVDA
|
$837M |
| 3 |
TJX Companies
TJX
|
$533M |
| 4 |
CTLT
CATALENT, INC.
CTLT
|
$364M |
| 5 |
Starbucks
SBUX
|
$357M |
Sector Composition
| 1 | Technology | 35.94% |
| 2 | Healthcare | 18.89% |
| 3 | Consumer Discretionary | 9.38% |
| 4 | Financials | 9.11% |
| 5 | Industrials | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2501
1-800-Flowers.com
FLWS
$322M
| $95.5K | ﹤0.01% |
10,035
-147
| -1% | -$1.4K |
|
2502
Definitive Healthcare
DH
$412M
| $89.6K | ﹤0.01% |
16,434
-264
| -2% | -$1.44K |
|
2503
Zentalis Pharmaceuticals
ZNTL
$125M
| $86.7K | ﹤0.01% |
21,172
-285
| -1% | -$1.17K |
|
2504
CompoSecure
CMPO
$1.88B
| $83.5K | ﹤0.01% |
+14,792
| New | +$83.5K |
|
|
VERV
2505
DELISTED
Verve Therapeutics
VERV
| $73.3K | ﹤0.01% |
15,031
-256
| -2% | -$1.25K |
|
|
SRG
2506
Seritage Growth Properties
SRG
$210M
| $65.8K | ﹤0.01% |
14,079
-204
| -1% | -$954 |
|
2507
Grab Holdings Limited Warrant
GRABW
$9.88M
| $64.6K | ﹤0.01% |
403,754
| – | – |
|
2508
Angi Inc
ANGI
$806M
| $56K | ﹤0.01% |
2,925
-40
| -1% | -$766 |
|
2509
Biomea Fusion
BMEA
$114M
| $50.3K | ﹤0.01% |
11,200
-1,274,078
| -99% | -$5.73M |
|
2510
OPAL Fuels
OPAL
$63.5M
| $48.4K | ﹤0.01% |
+11,842
| New | +$48.4K |
|
2511
Cerence
CRNC
$398M
| $47.8K | ﹤0.01% |
16,919
-211
| -1% | -$596 |
|
2512
Heritage Global
HGBL
$67.1M
| $46.5K | ﹤0.01% |
18,914
-1,531
| -7% | -$3.77K |
|
|
SACH
2513
Sachem Capital Corp
SACH
$59.2M
| $34.1K | ﹤0.01% |
13,164
-11,854
| -47% | -$30.7K |
|
|
CTEV
2514
Claritev Corporation
CTEV
$1.13B
| $27.9K | ﹤0.01% |
1,768
-37
| -2% | -$583 |
|
2515
ProFrac Holding
ACDC
$673M
| – | – |
-45,039
| Closed | -$377K |
|
|
ACRE
2516
Ares Commercial Real Estate
ACRE
$278M
| – | – |
-30,896
| Closed | -$230K |
|
2517
Adaptive Biotechnologies
ADPT
$1.97B
| – | – |
-42,686
| Closed | -$137K |
|
2518
Adtran
ADTN
$779M
| – | – |
-1,046,234
| Closed | -$5.67M |
|
2519
Aehr Test Systems
AEHR
$771M
| – | – |
-11,790
| Closed | -$146K |
|
|
AFCG
2520
AFC Gamma
AFCG
$103M
| – | – |
-16,639
| Closed | -$141K |
|
2521
Allient
ALNT
$769M
| – | – |
-6,224
| Closed | -$222K |
|
2522
Amylyx Pharmaceuticals
AMLX
$891M
| – | – |
-14,717
| Closed | -$41.9K |
|
2523
Applied Digital
APLD
$3.69B
| – | – |
-38,020
| Closed | -$162K |
|
2524
Digital Turbine
APPS
$475M
| – | – |
-239,595
| Closed | -$628K |
|
2525
Anavex Life Sciences
AVXL
$813M
| – | – |
-32,213
| Closed | -$164K |
|